FIG. 1. Photographs (7 May 1965) of both hands and right arm of H.H. showing finger and wrist drop and the need for assistance in raising the forearm against gravity. Wasting of the hand muscles is also evident.
hand and the weakness spread to the elbow and shoulder. In March 1965, he was seen in a neurological and neurosurgical service and at this time there was obvious weakness of the right upper limb with some muscle wasting. Coaxse fasciculations and fine fibrillations of the deltoids were also observed. The muscular weakness was most marked in the right hand. especially in the flexors and the small muscles. The flexors and extensors of the wrist were also involved, as were the biceps, triceps, and pectoral muscles. There was no sensory deficit, the cranial nerves and neck movement were normal, and the tendon reflexes were generally brisk. A cervical myelogram showed no evidence of a space-occupying lesion or of atrophy of the spinal cord. Although nerve conduction velocity measurements were not made, the electromyogram was normal. It was concluded that the patient was suffering from motor neurone disease, and he was treated with vitamin B12. Hypertension (BP 180/120 mmHg) was unaccounted for.
At the time the patient first came to our attention in May 1965, his condition had apparently deteriorated. He complained of abdominal colic and difficulty with swallowing; he sweated easily and tended to bite his cheeks while chewing. Food would often stick in his mouth. Mentally the patient was depressed in both mood and intellectual activity, and his speech was dysarthric. There was demonstrable weakness of the orbicularis auris but the tongue extended normally and neck movements were powerful and full range. In the upper limbs muscular wasting was most marked bilaterally in the thenar and hypothenar eminences ( Fig. 1) and also affected the interossei muscles. The forearms, upper arms, and shoulder girdles showed little wasting but fasciculations were prominent and there was loss of tone and power. Movement of the forearms and hands against gravity was limited to a short distance and could be sustained for a brief period only. The biceps, triceps, and supinator tendon reflexes were very brisk bilaterally. He walked with a shuffling gait. Although the tone in the lower limbs was normal, some loss of power seemed evident. Clonus was also very marked bilaterally and he had a positive Babinski on the right. The ankle and knee reflexes were pathologically brisk on both sides. There was no sensory loss.
Althouth an inquiry into the patient's occupational history had established that he had served as an oiler on a municipal dragline crew for a six-month period from June to the end of November 1964, it revealed no information that might indicate exposure to lead. Nevertheless a 24-hour urine volume from the patient was submitted to a central laboratory for analysis. The result, 0-17 mg Pb/l of urine, fell within the occupationally hazardous range (0 15-0-20 mg/l) of the laboratory and stimulated the patient to reflect on substances that he had handled within the past year. In the event he queried the composition of the white grease he had handled without gloves during employment the previous summer and autumn. This 'grease' was in fact pure basic carbonate of lead ground in pure linseed oil.
A repeat urinalysis before chelation therapy was started gave a lead concentration of 0-05 mg/l and fell within the non-occupational range (0 01-0 06 mg/I) of the laboratory. On the second day of the first course of treatment with disodium versenate (I g iv twice daily for five days) the urinary lead level was again 0-17 mg/l and indicated a 24-hour excretion rate of 0A40 mg of lead.
Other laboratory data collected in May 1965 or later were as follows: Haemoglobin 13-8 g/100 ml (88-4%), haematocrit 43 %, MCV 85 cubic microns, MCH 25 pg, MCHC 29 g/100 ml; no basophilic stippling, WBC 6950/mm3 with 69% polymorphs, 25% lymphocytes, Lead content ofneuromuscular tissue in amyotrophic lateral sclerosis 277 was 100 mg/100 ml, serum iron 69 ,g/100 ml, theBUN 17, and total coproporphyrin 277 pg/24 hours (laboratory normal range 80-250 pLg/24 hours). The blood lead level was not determined.
From May to early August 1965 he received four courses of disodium versenate. During the first two treatments, beginning 8 May and 17 May respectively, there was objective improvement in the patient, notably in his ability to appose the forefinger and thumb of either hand, abduct and extend the fingers, extend the hands at the wrists, and raise the arms above the head from a supine position. In addition, he 'had less difficulty moving about' and was able to bath or shower, initially with assistance, and then by himself. 
Electron microprobe analysis
In view of the history of lead exposure, sections of liver, spleen, kidney, pons, cerebellum, median nerve, and skeletal muscle were examined for lead with an electron microprobe, an instrument which has been used for elemental analysis of biological tissue (Mellors and Carroll, 1961; Tousimis, 1963; Carroll, Spinelli, and Goyer, 1970) . No detectable amount of lead was found in any of the tissues except nerve and muscle. Samples of medium nerve and psoas muscle from other unrelated necropsies failed to show detectable quantities of lead, thus suggesting that the lead level was increased in the nerve and muscle samples obtained from the case. Use of the electron microprobe in detailed local chemical analysis of the nerve and muscle samples showed that no detectable amount of lead existed in the attached adipose tissue. The lead therefore appeared to be associated with both nerve and muscle.
Quantifying the absolute content of lead in the nerve and muscle samples by electron microprobe is hampered by various factors, such as the heterogeneous distribution of the lead and choice of suitable reference material. These factors may have been the basis for the failure to detect lead in any of the tissues other than nerve and muscle. The samples were therefore analysed for lead by emission spectrography.
Emission spectrography
In preparation for analysis by emission spectrography samples of median nerve, spinal cord, and muscle from the case were first dried at 90°C for 10 hours and weighed. They were then placed in separate platinum dishes and heated gradually from 100°C to 350°C in air. The temperature was raised abruptly to 550°C, reducing each sample to approximately 1 mg. Each sample was then mixed with 3 mg of lithium fluoride powdered buffer, packed in an ultracarbon electrode, and excited in a Jarrell Ash 3 metre Ebert mount Spectrograph. The photoplates were developed and the density of the lead line at 283.307 nm (2833.07 A' inFigs. 4 and 5) was measured with a Jarrell Ash Microdensitometer. Figure FIG 4 shows a portion of the 235.00-435.00 nm emission spectrum obtained after exciting a small sample of the pure white lead (carbonate) that the patient had been exposed to in 1964. It shows only the lead lines at 280.199 and 283.307 rim and indicates the purity of the lead to which the patient was exposed. Figure  5 is a record of a portion of the emission spectrum of a sample of muscle that contained 27 ,ug of lead per gram of dry weight. It was found that the mean lead content (,ug/g dry weight of tissue) of nerve, cervical segment of spinal cord, heart muscle, and skeletal muscle was 9-6 + 0 3, 9.9 + 1.7, 17.7, and 21 2 + 5 1, respectively. Similar analysis of the standardmaterials used to fix the specimens failed to show detectable quantities of lead and therefore established that the lead was associated with the tissue. These data show that in this case the lead levels in nerve, muscle, and spinal cord were comparable in magnitude to those found in similar tissues many years ago in a particular case of lead paralysis (Herter, 1895 Lead in ALS and control groups A lead content (,ug/g dry weight) of 17-7 and 21-2 in heart and skeletal muscle, respectively, is much higher than the recently reported values of 0-26-0-30 in either muscle for a large series of necropsies not involving ALS or known exposure to lead (Barry and Mossman, 1970; Soman et al., 1970) . This observation combined with the need for more data on the lead content of spinal cord and nerve tissue suggested measurements by emission spectrography of the lead present in nerve, cervical segment of spinal cord, and skeletal muscle tissue in two series-one involving ALS (ALS group), and another not involving either ALS or known lead exposure (control group). For the latter group specimens from 12 necropsies were obtained and the data are given in Table 1 . It may be noted that in this mixed group the mean value for the lead content in muscle compares. with that reported from several large series (Barry and Mossman, 1970) The clinical signs of bulbar palsy, pyramidal tract involvement, and the normal electromyogram are also consistent with leadpoisoning (Simpson, Seaton, and Adams, 1964; Campbell et al., 1970) , although the partial and only transient recovery following chelation therapy contrasts with the much better result obtained elsewhere (Simpson et al., 1964) .
Nevertheless failure of lead-poisoned patients to respond to chelation therapy has been noted before (Campbell et al., 1970) .
However, the unexpected finding of elevated lead levels in neuromuscular tissue from the ALS group (Table 2 ) made the diagnosis of lead poisoning in the H.H. case uncertain and initiated a re-examination (by J.H.) of the neuropathology in this group using available necropsy material (cases 1, 2, and 3; Table  2 ).
In case 1, the spinal cord of this 66-year-old housewife exhibited pallor of the lateral corticospinal tracts with slight microgliosis. The medullary pyramids were not involved. There was marked and unequivocal neuromuscular atrophy of the tongue (Fig. 6 ) but the hypoglossal nucleus looked normal.
In case 2, there was no convincing evidence of cortical neuronal disease in this 75-year-old pensioner. Interpretation of this fact must be qualified by the uncertainty in the identification of the portion of the motor cortex that was sectioned at necropsy. There was loss of myelin in the medullary pyramids as well as decussation and prominent pallor of the lateral corticospinal tracts throughout the length of the spinal cord (Fig. 7) . No firm evidence of anterior horn cell disease was found other than the presence of lipofuscin. The hypoglossal nucleus appeared normal but a section of tongue was not available. Atrophic muscle fibres were present in the left arm and to a lesser degree in the rignt. The atrophic fibres lay within fascicles that contained fibres of normal size. Similar changes were noted in the muscles of the lower limbs. Since no firm evidence ofanterior horn cell disease was found the significance of the isolated muscle fibre atrophy is uncertain because similar changes occur through d,isuse in elderly debilitated patients.
The third case (3, Table 2 ) was that of a 38-year-old hydro labourer. This man exhibited pallor of both the medullary pyramids (Fig. 8) and the lateral corticospinal tracts (Fig. 9) . Both regions contained perivascular accumulations of swollen microglial cells (Figs. 10 and 11) , as did the anterior horns. There was a paucity of anterior horn cells (Fig. 12) . In the hypoglossal nucleus a neurone was found to contain a large eosinophillic cytoplasmic inclusion body (Fig. 13) (Goyer and Krall, 1969) .
The particular sensitivity of the human central nervous system to the toxic effects of lead (Goyer et al., 1970) may represent a direct clinical indicator that neuromuscular tissue has a peculiar affinity for the metal. If so, then more data on lead levels in neuromuscular tissue in demyelinating diseases is required to establish the relationship. The affinity of red cell (Patterson, 1965; Haeger-Aronsen, 1971) and mitochondrial (White and Harvey, 1972) membranes for lead has been noted and discussed in terms of its biochemical and chemical reactivity with sulphydryl groups (Plerovska and Teisinger, 1970; Chisolm, 1971) . Although an earlier report, based on two cases, suggests that the concentration of lead in nerve tissue in ALS may be normal (Currier and Haerer, 1968) , the present data suggest that it can be otherwise, at least in some cases. While both methods ofanalysis employed a spectrochemical technique (Kehoe, Cholak, and Story, 1940; Kehoc, 1964; Currier and Haerer, 1968 ) the apparent contradiction may not be real for reasons given in the introductory remarks and because of the fact that it has long been recognized that the response to lead varies from one individual to another (Cantarow and Trumper, 1944; Lane, 1949) . The extent to which dietary habits, infections (Weiner, Johnson, and Herndon, 1973) , malnutrition, anaemia (Goyer, 1971) , and metabolic factors determine the degree of susceptibility is poorly understood. However, the recently reported data, relating elevated lead levels to an enzyme deficiency (glucose-6-phosphate dehydrogenase (McIntire and Angle, 1972) 
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group.bmj.com on June 19, 2017 -Published by http://oem.bmj.com/ Downloaded from 286 A. Petkau, A. Sawatzky, C. R. Hillier, and J. Hoogstraten determined differences in frequency and distribution of 'protective' sulphydryl groups near the active site of sulphydryl-containing enzymes or other receptor proteins important to electrophysiological function may be another basis for variability in sensitivity to the toxic effects of lead. Associated conformational differences may affect the extent to which these molecules are then accessible to chelates and thus determine the variable effectiveness of chelation therapy (Campbell et al., 1970) .
In view of the increased amount of lead present in neuromuscular tissue in the ALS group it will be of interest to determine in what cellular structures the metal is concentrated. In association with the cell membrane a structural basis for the obvious disruption of neuromuscular function would be provided. On the other hand, experimental evidence suggests that lead binds to the endoplasmic reticulum (Choie and Richter, 1972) and affects mitochondria (Koeppe and Miller, 1970; Cardona, Lessler, and Brierley, 1971) . The latter effect is particularly interesting, not only because it is accentuated during inorganic phosphate deficiency, but also because it disrupts the fundamental reactions of energy transduction and tissue respiration. In animals this results in elevated norepinephrine levels (Krall, Pesavanto, Harmon, and Packer, 1972) , an observation that might have some relevance in accounting for the hypertension in the H.H. case.
From the foregoing remarks it is clear that the biochemical and physiological consequences of increased tissue lead levels are several and varied. To establish the extent to which these effects are manifest in cases of ALS, in which the lead content in neuromuscular tissue may be shown to be elevated, more investigative work will be required in the direction suggested by this report. Adequate clinical material seems to be available (Bobowick and Brody, 1973 
